age 18 Years to 80 Years
Item
Alter 18 bis 80 Jahre
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Subjects with a documented at least 6 months history of unilateral or bilateral intermediate uveitis either idiopathic or due to non-infectious systemic disease (e.g. sarcoidosis, multiple sclerosis)
Item
Subjects with a documented at least 6 months history of unilateral or bilateral intermediate uveitis either idiopathic or due to non-infectious systemic disease (e.g. sarcoidosis, multiple sclerosis)
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0205092 (UMLS CUI 2011AA)
66459002 (SNOMED CT 2011_0131)
C0238767 (UMLS CUI 2011AA)
51440002 (SNOMED CT 2011_0131)
C0042166 (UMLS CUI 2011AA)
314429009 (SNOMED CT 2011_0131)
10022557 (MedDRA 14.1)
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0332240 (UMLS CUI 2011AA)
54690008 (SNOMED CT 2011_0131)
CL420107 (UMLS CUI 2011AA)
C1518422 (UMLS CUI 2011AA)
C0009450 (UMLS CUI 2011AA)
257551009 (SNOMED CT 2011_0131)
10021789 (MedDRA 14.1)
C0442893 (UMLS CUI 2011AA)
56019007, 264578000 (SNOMED CT 2011_0131)
C0036202 (UMLS CUI 2011AA)
31541009 (SNOMED CT 2011_0131)
10039486 (MedDRA 14.1)
D86.9 (ICD-10-CM Version 2010)
135 (ICD-9-CM Version 2011)
C0026769 (UMLS CUI 2011AA)
24700007 (SNOMED CT 2011_0131)
10028245 (MedDRA 14.1)
MTHU020805 (LOINC Version 232)
G35 (ICD-10-CM Version 2010)
340 (ICD-9-CM Version 2011)
Uveitis has to be considered to be active at the timepoint of enrolment according to at least one of the following criteria:
Item
Uveitis has to be considered to be active at the timepoint of enrolment according to at least one of the following criteria:
boolean
C0042164 (UMLS CUI 2011AA)
Grade 2+ or higher for vitreous haze
Item
Grade 2+ or higher for vitreous haze
boolean
C0441800 (UMLS CUI 2011AA)
258349007 (SNOMED CT 2011_0131)
MTHU003112 (LOINC Version 232)
C0152006 (UMLS CUI 2011AA)
422061002 (SNOMED CT 2011_0131)
10047658 (MedDRA 14.1)
Grade 2+ or higher for anterior chamber cells
Item
Grade 2+ or higher for anterior chamber cells
boolean
C0441800 (UMLS CUI 2011AA)
258349007 (SNOMED CT 2011_0131)
MTHU003112 (LOINC Version 232)
C0423282 (UMLS CUI 2011AA)
246993000 (SNOMED CT 2011_0131)
10053781 (MedDRA 14.1)
Presence of cystoid macular edema in OCT
Item
Presence of cystoid macular edema in OCT
boolean
C0150312 (UMLS CUI 2011AA)
52101004 (SNOMED CT 2011_0131)
C0024440 (UMLS CUI 2011AA)
193387007 (SNOMED CT 2011_0131)
10058202 (MedDRA 14.1)
C0920367 (UMLS CUI 2011AA)
392010000 (SNOMED CT 2011_0131)
10057208 (MedDRA 14.1)
Presence of retinal vessel leakage in FA
Item
Presence of retinal vessel leakage in FA
boolean
C0150312 (UMLS CUI 2011AA)
52101004 (SNOMED CT 2011_0131)
C0035330 (UMLS CUI 2011AA)
28758002 (SNOMED CT 2011_0131)
C0015376 (UMLS CUI 2011AA)
76676007 (SNOMED CT 2011_0131)
10015866 (MedDRA 14.1)
C0016313 (UMLS CUI 2011AA)
172581008 (SNOMED CT 2011_0131)
Considered by the investigator to require systemic treatment.
Item
Considered by the investigator to require systemic treatment.
boolean
C1514873 (UMLS CUI 2011AA)
C1515119 (UMLS CUI 2011AA)
Not planning to undergo elective ocular surgery during the study
Item
Not planning to undergo elective ocular surgery during the study
boolean
C1518422 (UMLS CUI 2011AA)
C1301732 (UMLS CUI 2011AA)
397943006 (SNOMED CT 2011_0131)
C0439608 (UMLS CUI 2011AA)
103390000 (SNOMED CT 2011_0131)
C1705869 (UMLS CUI 2011AA)
422191005 (SNOMED CT 2011_0131)
Capable of understanding the purposes and risks of the study, able to give informed consent and to comply with the study requirements
Item
Capable of understanding the purposes and risks of the study, able to give informed consent and to comply with the study requirements
boolean
C0021430 (UMLS CUI 2011AA)
Subjects of both gender with reproductive potential who are sexually active agree to use contraception throughout the course of the study and for at least 3 months after completion of their study participation.
Item
Subjects of both gender with reproductive potential who are sexually active agree to use contraception throughout the course of the study and for at least 3 months after completion of their study participation.
boolean
C0681850 (UMLS CUI 2011AA)
C1706086 (UMLS CUI 2011AA)
C0079399 (UMLS CUI 2011AA)
263495000 (SNOMED CT 2011_0131)
MTHU002975 (LOINC Version 232)
C0035150 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C0241028 (UMLS CUI 2011AA)
228453005 (SNOMED CT 2011_0131)
10066098 (MedDRA 14.1)
C0680240 (UMLS CUI 2011AA)
C0700589 (UMLS CUI 2011AA)
146680009 (SNOMED CT 2011_0131)
10010808 (MedDRA 14.1)
Women of childbearing potential have to use a highly effective method of birth control defined as one which results in a low failure rate (i.e. < 1% per year) when used consistently and correctly, such as implants, injectables, combined oral contraceptives, hormonal IUDs combined with barrier methods (e.g. condom, diaphragm or spermicide), sexual abstinence or vasectomised partner.
Item
Women of childbearing potential have to use a highly effective method of birth control defined as one which results in a low failure rate (i.e. < 1% per year) when used consistently and correctly, such as implants, injectables, combined oral contraceptives, hormonal IUDs combined with barrier methods (e.g. condom, diaphragm or spermicide), sexual abstinence or vasectomised partner.
boolean
C0043210 (UMLS CUI 2011AA)
224526002 (SNOMED CT 2011_0131)
C1148523 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C0027552 (UMLS CUI 2011AA)
410525008 (SNOMED CT 2011_0131)
C0700589 (UMLS CUI 2011AA)
146680009 (SNOMED CT 2011_0131)
10010808 (MedDRA 14.1)
CL424925 (UMLS CUI 2011AA)
C1262153 (UMLS CUI 2011AA)
10062577 (MedDRA 14.1)
C0457572 (UMLS CUI 2011AA)
268458002 (SNOMED CT 2011_0131)
C0458083 (UMLS CUI 2011AA)
278994005 (SNOMED CT 2011_0131)
C0021900 (UMLS CUI 2011AA)
268460000 (SNOMED CT 2011_0131)
10022745 (MedDRA 14.1)
C0004764 (UMLS CUI 2011AA)
225370004 (SNOMED CT 2011_0131)
C0677582 (UMLS CUI 2011AA)
C0042241 (UMLS CUI 2011AA)
20359006 (SNOMED CT 2011_0131)
C0037862 (UMLS CUI 2011AA)
425484006 (SNOMED CT 2011_0131)
C0036899 (UMLS CUI 2011AA)
47037006 (SNOMED CT 2011_0131)
10029805 (MedDRA 14.1)
C0420842 (UMLS CUI 2011AA)
268457007 (SNOMED CT 2011_0131)
Women of childbearing age must have a negative urine pregnancy test (UPT) within 48 hours prior to starting study drug and must not be lactating.
Item
Women of childbearing age must have a negative urine pregnancy test (UPT) within 48 hours prior to starting study drug and must not be lactating.
boolean
C0043210 (UMLS CUI 2011AA)
224526002 (SNOMED CT 2011_0131)
C1148523 (UMLS CUI 2011AA)
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
C0027552 (UMLS CUI 2011AA)
410525008 (SNOMED CT 2011_0131)
C0430057 (UMLS CUI 2011AA)
167254001 (SNOMED CT 2011_0131)
10036577 (MedDRA 14.1)
C2826207 (UMLS CUI 2011AA)
Female subjects of non-childbearing potential must meet at least one of the following criteria:
Item
Female subjects of non-childbearing potential must meet at least one of the following criteria:
boolean
C0086287 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C1518422 (UMLS CUI 2011AA)
C1148523 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C1550543 (UMLS CUI 2011AA)
FLFS (HL7 V3 2006_05)
C0205447 (UMLS CUI 2011AA)
38112003 (SNOMED CT 2011_0131)
C0332282 (UMLS CUI 2011AA)
255260001 (SNOMED CT 2011_0131)
CL414621 (UMLS CUI 2011AA)
Postmenopausal females, defined as:
Item
Postmenopausal females, defined as:
boolean
C0232970 (UMLS CUI 2011AA)
76498008 (SNOMED CT 2011_0131)
C0086287 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C1704788 (UMLS CUI 2011AA)
Females over the age of 60 years.
Item
Females over the age of 60 years.
boolean
C0086287 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Females who are 45 to 60 years of age must be amenorrheic for at least 2 years.
Item
Females who are 45 to 60 years of age must be amenorrheic for at least 2 years.
boolean
C0086287 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
C0002453 (UMLS CUI 2011AA)
14302001 (SNOMED CT 2011_0131)
10001928 (MedDRA 14.1)
N91.2 (ICD-10-CM Version 2010)
626.0 (ICD-9-CM Version 2011)
C0205448 (UMLS CUI 2011AA)
19338005 (SNOMED CT 2011_0131)
C0439234 (UMLS CUI 2011AA)
258707000 (SNOMED CT 2011_0131)
Y (HL7 V3 2006_05)
Females who had a hysterectomy and/or bilateral oophorectomy.
Item
Females who had a hysterectomy and/or bilateral oophorectomy.
boolean
C0086287 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C0020699 (UMLS CUI 2011AA)
236886002 (SNOMED CT 2011_0131)
10021151 (MedDRA 14.1)
C0278321 (UMLS CUI 2011AA)
76876009 (SNOMED CT 2011_0131)
10030339 (MedDRA 14.1)
65.51 (ICD-9-CM Version 2011)
Uveitis of infectious etiology
Item
Uveitis of infectious etiology
boolean
C0042164 (UMLS CUI 2011AA)
Signs of tuberculosis in chest x-ray during the past 12 months before study entry
Item
Signs of tuberculosis in chest x-ray during the past 12 months before study entry
boolean
C0220912 (UMLS CUI 2011AA)
C0041296 (UMLS CUI 2011AA)
56717001 (SNOMED CT 2011_0131)
10044755 (MedDRA 14.1)
MTHU020835 (LOINC Version 232)
A15-A19 (ICD-10-CM Version 2010)
010-018.99 (ICD-9-CM Version 2011)
C0039985 (UMLS CUI 2011AA)
399208008 (SNOMED CT 2011_0131)
10008498 (MedDRA 14.1)
Clinically suspected or confirmed central nervous system or ocular lymphoma
Item
Clinically suspected or confirmed central nervous system or ocular lymphoma
boolean
C0280803 (UMLS CUI 2011AA)
307649006 (SNOMED CT 2011_0131)
10007953 (MedDRA 14.1)
200.5 (ICD-9-CM Version 2011)
C1706527 (UMLS CUI 2011AA)
420788006 (SNOMED CT 2011_0131)
Primary diagnosis of anterior or posterior uveitis
Item
Primary diagnosis of anterior or posterior uveitis
boolean
C0801658 (UMLS CUI 2011AA)
18630-4 (LOINC Version 232)
C0042165 (UMLS CUI 2011AA)
410692006 (SNOMED CT 2011_0131)
10046852 (MedDRA 14.1)
C0042167 (UMLS CUI 2011AA)
43363007 (SNOMED CT 2011_0131)
10036370 (MedDRA 14.1)
Uncontrolled glaucoma or known steroid response
Item
Uncontrolled glaucoma or known steroid response
boolean
C0205318 (UMLS CUI 2011AA)
19032002 (SNOMED CT 2011_0131)
C0017601 (UMLS CUI 2011AA)
23986001 (SNOMED CT 2011_0131)
10018304 (MedDRA 14.1)
MTHU020819 (LOINC Version 232)
H40-H42 (ICD-10-CM Version 2010)
365 (ICD-9-CM Version 2011)
E10392 (CTCAE 1105E)
C0038317 (UMLS CUI 2011AA)
116566001 (SNOMED CT 2011_0131)
C0871261 (UMLS CUI 2011AA)
Subjects who received treatment with a systemic immunosuppressive drug, a monoclonal antibody or any other biologic therapy within 90 days prior study entry
Item
Subjects who received treatment with a systemic immunosuppressive drug, a monoclonal antibody or any other biologic therapy within 90 days prior study entry
boolean
C0039798 (UMLS CUI 2011AA)
C0205373 (UMLS CUI 2011AA)
31099001 (SNOMED CT 2011_0131)
C0021081 (UMLS CUI 2011AA)
372823004, 69431002 (SNOMED CT 2011_0131)
C0003250 (UMLS CUI 2011AA)
49616005 (SNOMED CT 2011_0131)
C0005527 (UMLS CUI 2011AA)
Treatment with mycophenolate mofetil or mycophenolate sodium in the past
Item
Treatment with mycophenolate mofetil or mycophenolate sodium in the past
boolean
C0039798 (UMLS CUI 2011AA)
C0209368 (UMLS CUI 2011AA)
386976000 (SNOMED CT 2011_0131)
C1337395 (UMLS CUI 2011AA)
426216009 (SNOMED CT 2011_0131)
Treatment with a periocular steroid injection within 6 weeks prior to study entry
Item
Treatment with a periocular steroid injection within 6 weeks prior to study entry
boolean
C0039798 (UMLS CUI 2011AA)
C1444677 (UMLS CUI 2011AA)
410563000 (SNOMED CT 2011_0131)
Presence of absolute contraindications for Decortin H and/or Myfortic as mentioned in the product informations (Appendix 1 and 2)
Item
Presence of absolute contraindications for Decortin H and/or Myfortic as mentioned in the product informations (Appendix 1 and 2)
boolean
C0205344 (UMLS CUI 2011AA)
56136002 (SNOMED CT 2011_0131)
C1301624 (UMLS CUI 2011AA)
397745006 (SNOMED CT 2011_0131)
C0032950 (UMLS CUI 2011AA)
116601002 (SNOMED CT 2011_0131)
MTHU003522 (LOINC Version 232)
C0026933 (UMLS CUI 2011AA)
409330005 (SNOMED CT 2011_0131)
Presence of relative contraindications for Decortin H and/or Myfortic as mentioned in the product information (Appendix 1 and 2) if the disorder leading to the relative contraindication can not sufficiently managed by concomitant medication.
Item
Presence of relative contraindications for Decortin H and/or Myfortic as mentioned in the product information (Appendix 1 and 2) if the disorder leading to the relative contraindication can not sufficiently managed by concomitant medication.
boolean
C0205345 (UMLS CUI 2011AA)
29920004 (SNOMED CT 2011_0131)
C1301624 (UMLS CUI 2011AA)
397745006 (SNOMED CT 2011_0131)
C0032950 (UMLS CUI 2011AA)
116601002 (SNOMED CT 2011_0131)
MTHU003522 (LOINC Version 232)
C0026933 (UMLS CUI 2011AA)
409330005 (SNOMED CT 2011_0131)
C0750557 (UMLS CUI 2011AA)
C1444657 (UMLS CUI 2011AA)
410536001 (SNOMED CT 2011_0131)
C0012634 (UMLS CUI 2011AA)
64572001 (SNOMED CT 2011_0131)
C1518422 (UMLS CUI 2011AA)
C0205410 (UMLS CUI 2011AA)
51117008 (SNOMED CT 2011_0131)
CL415147 (UMLS CUI 2011AA)
Recipients of a solid organ transplant
Item
Recipients of a solid organ transplant
boolean
C1709854 (UMLS CUI 2011AA)
C0730400 (UMLS CUI 2011AA)
313039003 (SNOMED CT 2011_0131)
Subjects with lens opacities or obscured ocular media upon enrolment making unable evaluation of the posterior eye segment
Item
Subjects with lens opacities or obscured ocular media upon enrolment making unable evaluation of the posterior eye segment
boolean
C1510497 (UMLS CUI 2011AA)
193570009 (SNOMED CT 2011_0131)
10024214 (MedDRA 14.1)
CL427838 (UMLS CUI 2011AA)
C1299003 (UMLS CUI 2011AA)
C0522503 (UMLS CUI 2011AA)
300828005 (SNOMED CT 2011_0131)
C0439861 (UMLS CUI 2011AA)
105590001 (SNOMED CT 2011_0131)
C1299582 (UMLS CUI 2011AA)
371151008 (SNOMED CT 2011_0131)
C0220825 (UMLS CUI 2011AA)
C0278450 (UMLS CUI 2011AA)
280659009 (SNOMED CT 2011_0131)
Subjects with a history of herpes zoster or varicella infection within 3 months before enrollment
Item
Subjects with a history of herpes zoster or varicella infection within 3 months before enrollment
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0019360 (UMLS CUI 2011AA)
4740000 (SNOMED CT 2011_0131)
10019974 (MedDRA 14.1)
B02 (ICD-10-CM Version 2010)
53 (ICD-9-CM Version 2011)
C0008049 (UMLS CUI 2011AA)
38907003 (SNOMED CT 2011_0131)
10046980 (MedDRA 14.1)
B01 (ICD-10-CM Version 2010)
52 (ICD-9-CM Version 2011)
Active, extraocular infection requiring the prolonged or chronic use of antimicrobial agents or the history/presence of active hepatitis A, B or C
Item
Active, extraocular infection requiring the prolonged or chronic use of antimicrobial agents or the history/presence of active hepatitis A, B or C
boolean
C0241886 (UMLS CUI 2011AA)
C0009450 (UMLS CUI 2011AA)
257551009 (SNOMED CT 2011_0131)
10021789 (MedDRA 14.1)
C1514873 (UMLS CUI 2011AA)
C0205191 (UMLS CUI 2011AA)
90734009 (SNOMED CT 2011_0131)
C1136254 (UMLS CUI 2011AA)
250428009 (SNOMED CT 2011_0131)
MTHU014499 (LOINC Version 232)
C0019159 (UMLS CUI 2011AA)
40468003 (SNOMED CT 2011_0131)
10019780 (MedDRA 14.1)
C0019163 (UMLS CUI 2011AA)
66071002 (SNOMED CT 2011_0131)
10019731 (MedDRA 14.1)
C0019196 (UMLS CUI 2011AA)
50711007 (SNOMED CT 2011_0131)
10019744 (MedDRA 14.1)
B19.20 (ICD-10-CM Version 2010)
070.7 (ICD-9-CM Version 2011)
Seropositivity for human immunodeficiency virus (HIV)
Item
HIV-positiv
boolean
C0019699 (UMLS CUI 2011AA)
165816005 (SNOMED CT 2011_0131)
10020188 (MedDRA 14.1)
Z21 (ICD-10-CM Version 2010)
Alanine transaminase (ALT), aspartate transaminase (AST), or gamma-glutamyl transferase (GGT) >= 2x upper limit of normal (ULN)
Item
Alanine transaminase (ALT), aspartate transaminase (AST), or gamma-glutamyl transferase (GGT) >= 2x upper limit of normal (ULN)
boolean
C0001899 (UMLS CUI 2011AA)
56935002 (SNOMED CT 2011_0131)
MTHU006766 (LOINC Version 232)
C0004002 (UMLS CUI 2011AA)
26091008 (SNOMED CT 2011_0131)
MTHU004883 (LOINC Version 232)
C0017040 (UMLS CUI 2011AA)
60153001 (SNOMED CT 2011_0131)
MTHU001941 (LOINC Version 232)
C1519815 (UMLS CUI 2011AA)
Severe anemia (hemoglobin < 8 g/dL), leukopenia (white blood cell count [WBC] < 2500 mm3), thrombocytopenia (platelet count < 80,000 mm3)
Item
Severe anemia (hemoglobin < 8 g/dL), leukopenia (white blood cell count [WBC] < 2500 mm3), thrombocytopenia (platelet count < 80,000 mm3)
boolean
C0205082 (UMLS CUI 2011AA)
24484000 (SNOMED CT 2011_0131)
C0002871 (UMLS CUI 2011AA)
271737000 (SNOMED CT 2011_0131)
10002034 (MedDRA 14.1)
MTHU020823 (LOINC Version 232)
D64.9 (ICD-10-CM Version 2010)
285.9 (ICD-9-CM Version 2011)
E10010 (CTCAE 1105E)
C0019046 (UMLS CUI 2011AA)
38082009 (SNOMED CT 2011_0131)
10019481 (MedDRA 14.1)
LP14449-0 (LOINC Version 232)
C0023530 (UMLS CUI 2011AA)
84828003 (SNOMED CT 2011_0131)
10024384 (MedDRA 14.1)
D72.819 (ICD-10-CM Version 2010)
288.50 (ICD-9-CM Version 2011)
E12232 (CTCAE 1105E)
C0023508 (UMLS CUI 2011AA)
767002 (SNOMED CT 2011_0131)
10047939 (MedDRA 14.1)
C0040034 (UMLS CUI 2011AA)
302215000 (SNOMED CT 2011_0131)
10043554 (MedDRA 14.1)
D69.6 (ICD-10-CM Version 2010)
287.5 (ICD-9-CM Version 2011)
E12207 (CTCAE 1105E)
C1287267 (UMLS CUI 2011AA)
365632008 (SNOMED CT 2011_0131)
777-3 (LOINC Version 232)
Current malignancy or a history of malignancy within the previous 5 years
Item
Krebs
boolean
C0006826 (UMLS CUI 2011AA)
363346000 (SNOMED CT 2011_0131)
10028997 (MedDRA 14.1)
MTHU010328 (LOINC Version 232)
C00-C96 (ICD-10-CM Version 2010)
Pregnant or lactating women
Item
Pregnant or lactating women
boolean
C0549206 (UMLS CUI 2011AA)
10036586 (MedDRA 14.1)
C2828358 (UMLS CUI 2011AA)
C0043210 (UMLS CUI 2011AA)
224526002 (SNOMED CT 2011_0131)
Known allergy for fluorescein natrium
Item
Known allergy for fluorescein natrium
boolean
C0020517 (UMLS CUI 2011AA)
257550005 (SNOMED CT 2011_0131)
T78.40 (ICD-10-CM Version 2010)
C1618612 (UMLS CUI 2011AA)
25351006 (SNOMED CT 2011_0131)
Currently participating in another clinical trial with an investigational agent in the 30 days prior to study participation and/or has not recovered from any reversible effects or side effects of prior investigational agent
Item
Currently participating in another clinical trial with an investigational agent in the 30 days prior to study participation and/or has not recovered from any reversible effects or side effects of prior investigational agent
boolean
C0679823 (UMLS CUI 2011AA)
PART (HL7 V3 2006_05)
C0205394 (UMLS CUI 2011AA)
74964007 (SNOMED CT 2011_0131)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
C0013230 (UMLS CUI 2011AA)
C1709277 (UMLS CUI 2011AA)
C0879626 (UMLS CUI 2011AA)
281647001 (SNOMED CT 2011_0131)
10067484 (MedDRA 14.1)
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C0013230 (UMLS CUI 2011AA)
Subjects with non-ocular, medically significant co-morbid conditions that impair normal activities, require systemic corticosteroids or immunosuppressives, or any medical condition that would likely have an impact on the participant´s ability to comply with the study visit schedule
Item
Subjects with non-ocular, medically significant co-morbid conditions that impair normal activities, require systemic corticosteroids or immunosuppressives, or any medical condition that would likely have an impact on the participant´s ability to comply with the study visit schedule
boolean
C1518422 (UMLS CUI 2011AA)
C1299003 (UMLS CUI 2011AA)
C1275743 (UMLS CUI 2011AA)
398192003 (SNOMED CT 2011_0131)
C1514873 (UMLS CUI 2011AA)
C0205373 (UMLS CUI 2011AA)
31099001 (SNOMED CT 2011_0131)
C0001617 (UMLS CUI 2011AA)
79440004 (SNOMED CT 2011_0131)
C0021081 (UMLS CUI 2011AA)
372823004, 69431002 (SNOMED CT 2011_0131)
C1699700 (UMLS CUI 2011AA)
MEDCCAT (HL7 V3 2006_05)
C1280500 (UMLS CUI 2011AA)
253861007 (SNOMED CT 2011_0131)
C0085732 (UMLS CUI 2011AA)
371150009 (SNOMED CT 2011_0131)
C0525058 (UMLS CUI 2011AA)
Any current or history of substance abuse, psychiatric disorder or a condition that, in the opinion of the investigator, may invalidate communication
Item
Any current or history of substance abuse, psychiatric disorder or a condition that, in the opinion of the investigator, may invalidate communication
boolean
C0740858 (UMLS CUI 2011AA)
66214007 (SNOMED CT 2011_0131)
10066169 (MedDRA 14.1)
MTHU019364 (LOINC Version 232)
C0004936 (UMLS CUI 2011AA)
74732009 (SNOMED CT 2011_0131)
10037174 (MedDRA 14.1)
F99 (ICD-10-CM Version 2010)
290-319.99 (ICD-9-CM Version 2011)
C0348080 (UMLS CUI 2011AA)
260905004 (SNOMED CT 2011_0131)
COND (HL7 V3 2006_05)
C0678227 (UMLS CUI 2011AA)
23981006 (SNOMED CT 2011_0131)
C1883420 (UMLS CUI 2011AA)
C0009452 (UMLS CUI 2011AA)
263536004 (SNOMED CT 2011_0131)
MTHU021752 (LOINC Version 232)